Cytomegalovirus (CMV) is a formidable pathogen after solid organ or hematopoietic cell transplant. During this engaging activity, Drs. Humar and Papanicolaou and an experienced patient discuss best practices for CMV prevention and treatment after transplantation. Learn how to incorporate newer therapeutic options for CMV to improve outcomes in your transplant patients.
Upon completion of this activity, participants should be better able to:
Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada
Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor, Medicine
Weill Cornell Medical College, Cornell University
New York, NY, United States
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources